Topic: How To Invest

Hi Pat, what’s your investment opinion on Ev3? Thanks.

Article Excerpt

Ev3 Inc., $7.35, symbol EVVV on Nasdaq (Shares outstanding: 106.7 million; Market cap: $784 million), develops technologies for the treatment of a wide range of vascular and neurovascular diseases. Ev3 offers a number of treatment options, including the main technologies used today: peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. Ev3 is showing steadily rising sales and profits. However, the company faces a lot of competition, including from C.R. Bard Inc. (symbol BCR on New York), which is recommended by our Wall Street Stock Forecaster newsletter. Ev3’s shares have more than doubled since last November. The stock trades at about 157 times forecast 2009 earnings of $0.05 a share. We don’t recommend Ev3. Ev3. …